Key facts
- Laurion Capital Management is a hedge fund based in New York, United States with 5 tracked portfolio companies.
- Notable positions include Scipher Medicine, TRexBio, MerQube, Delio Group, Libertify.
- Laurion Capital Management reports $6.8B in regulatory assets under management across 3 private funds, per its SEC Form ADV (2026-03).
About Laurion Capital Management
Founded in 2005
Registered with the SEC
Form ADV · 2026-03 · CRD 161278- Regulatory AUM
- $6.8B
- Private fund assets
- $10.7B
- Private funds
- 3 · 3 hedge
- Staff
- 59
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as LAURION CAPITAL MANAGEMENT LP).
Free account
See the whole book
- ·Watchlist + alerts for Laurion Capital Management's activity
Create free account
No card required
Portfolio, priced
5 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Scipher Medicine | Discovery Tools (Healthcare) | $495.9M | — | |
| TRexBio | — | $274.0M | — | |
| MerQube | — | $122.0M | — | |
| Delio Group | — | $19.6M | — | |
| Libertify | — | $17.0M | — |
Frequently asked
- What companies does Laurion Capital Management invest in?
- Laurion Capital Management has 5 recorded portfolio companies, including Scipher Medicine, TRexBio, MerQube, Delio Group.